Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

NCT01541904 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Reformulation

Conditions

Ocular Itching
Ocular Allergy
Seasonal Allergic Conjunctivitis
Perennial Allergic Conjunctivitis
Conjunctivitis, Allergic

Interventions

DRUG: PRO-118 Ophthalmic Solution 0.015%
DRUG: PRO-118 Ophthalmic Solution 0.015 %
DRUG: PRO-118 Ophthalmic Solution 0.020 %
DRUG: PRO-118 Ophthalmic Solution 0.020 %
DRUG: Placebo Ophthalmic Solution

Sponsor

Laboratorios Sophia S.A de C.V.